O	O	O	0	6	Relief	Relief	B-NP	NN	O	0	ROOT	O
O	O	O	7	9	of	of	B-PP	IN	O	1	NMOD	O
T1	B-Protein	B-Protein	10	16	cyclin	cyclin	B-NP	NN	B-protein	4	NMOD	B-protein
T1	I-Protein	I-Protein	17	18	A	A	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	O	19	23	gene	gene	I-NP	NN	O	7	NMOD	O
O	O	O	24	39	transcriptional	transcriptional	I-NP	JJ	O	7	NMOD	O
O	O	O	40	50	inhibition	inhibition	I-NP	NN	O	2	PMOD	O
O	O	O	51	57	during	during	B-PP	IN	O	1	NMOD	O
O	O	O	58	68	activation	activation	B-NP	NN	O	8	PMOD	O
O	O	O	69	71	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	72	77	human	human	B-NP	JJ	B-cell_type	14	NMOD	B-cell_type
O	O	O	78	85	primary	primary	I-NP	JJ	I-cell_type	14	NMOD	I-cell_type
O	O	O	86	87	T	T	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	O	88	99	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	10	PMOD	I-cell_type
O	O	O	100	103	via	via	B-PP	IN	O	9	NMOD	O
T2	B-Protein	B-Protein	104	107	CD2	CD2	B-NP	NN	B-protein	18	NMOD	B-protein
O	O	O	108	111	and	and	I-NP	CC	O	18	NMOD	O
T3	B-Protein	B-Protein	112	116	CD28	CD28	I-NP	NN	B-protein	20	NMOD	B-protein
O	O	O	117	125	adhesion	adhesion	I-NP	NN	B-protein	20	NMOD	B-protein
O	O	O	126	135	molecules	molecule	I-NP	NNS	I-protein	15	PMOD	I-protein
O	O	O	135	136	.	.	O	.	O	1	P	O

T4	B-Protein	B-Protein	138	144	Cyclin	Cyclin	B-NP	NN	B-protein	2	NMOD	B-protein
T4	I-Protein	I-Protein	145	146	A	A	I-NP	NN	I-protein	3	NMOD	I-protein
O	O	O	147	160	transcription	transcription	I-NP	NN	O	4	SUB	O
O	O	O	161	163	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	164	168	cell	cell	B-NP	NN	O	6	NMOD	O
O	O	O	169	174	cycle	cycle	I-NP	NN	O	7	AMOD	O
O	O	O	175	184	regulated	regulate	B-VP	VBN	O	4	VMOD	O
O	O	O	185	188	and	and	I-VP	CC	O	7	DEP	O
O	O	O	189	196	induced	induce	I-VP	VBN	O	7	DEP	O
O	O	O	197	199	by	by	B-PP	IN	O	9	VMOD	O
O	O	O	200	204	cell	cell	B-NP	NN	O	13	NMOD	O
O	O	O	205	218	proliferative	proliferative	I-NP	JJ	O	13	NMOD	O
O	O	O	219	226	signals	signal	I-NP	NNS	O	10	PMOD	O
O	O	O	226	227	.	.	O	.	O	4	P	O

O	O	O	228	230	To	To	B-VP	TO	O	2	VMOD	O
O	O	O	231	241	understand	understand	I-VP	VB	O	15	VMOD	O
O	O	O	242	245	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	246	256	mechanisms	mechanism	I-NP	NNS	O	2	OBJ	O
O	O	O	257	267	underlined	underline	B-VP	VBN	O	4	NMOD	O
O	O	O	268	270	in	in	B-PP	IN	O	5	VMOD	O
O	O	O	271	275	this	this	B-NP	DT	O	8	NMOD	O
O	O	O	276	286	regulation	regulation	I-NP	NN	O	6	PMOD	O
O	O	O	287	289	in	in	B-PP	IN	O	8	NMOD	O
O	O	O	290	296	normal	normal	B-NP	JJ	B-cell_type	12	NMOD	B-cell_type
O	O	O	297	302	human	human	I-NP	JJ	I-cell_type	12	NMOD	I-cell_type
O	O	O	303	308	cells	cell	I-NP	NNS	I-cell_type	9	PMOD	I-cell_type
O	O	O	308	309	,	,	O	,	O	15	P	O
O	O	O	310	312	we	we	B-NP	PRP	O	15	SUB	O
O	O	O	313	317	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	318	326	analysed	analyse	I-VP	VBN	O	15	VC	O
O	O	O	327	329	in	in	B-NP	FW	O	18	AMOD	O
O	O	O	330	334	vivo	vivo	I-NP	FW	O	22	NMOD	O
O	O	O	335	342	protein	protein	I-NP	NN	O	22	NMOD	O
O	O	O	342	343	-	-	B-NP	HYPH	O	22	NMOD	O
O	O	O	343	346	DNA	DNA	I-NP	NN	O	22	NMOD	O
O	O	O	347	359	interactions	interaction	I-NP	NNS	O	16	OBJ	O
O	O	O	360	362	at	at	B-PP	IN	O	22	NMOD	O
O	O	O	363	366	the	the	B-NP	DT	O	27	NMOD	O
T5	B-Protein	B-Protein	367	373	Cyclin	Cyclin	I-NP	NN	B-protein	26	NMOD	B-protein
T5	I-Protein	I-Protein	374	375	A	A	I-NP	NN	I-protein	27	NMOD	I-protein
T20	B-Entity	B-Entity	376	381	locus	locus	I-NP	NN	O	23	PMOD	O
O	O	O	382	384	in	in	B-PP	IN	O	27	NMOD	O
O	O	O	385	392	primary	primary	B-NP	JJ	B-cell_type	31	NMOD	B-cell_type
O	O	O	393	394	T	T	I-NP	NN	I-cell_type	31	NMOD	I-cell_type
O	O	O	395	406	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	28	PMOD	I-cell_type
O	O	O	406	407	.	.	O	.	O	15	P	O

O	O	O	408	419	Stimulation	Stimulation	B-NP	NN	O	19	SUB	O
O	O	O	420	422	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	423	431	purified	purify	B-NP	VBN	B-cell_type	5	NMOD	B-cell_type
O	O	O	432	433	T	T	I-NP	NN	I-cell_type	5	NMOD	I-cell_type
O	O	O	434	445	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	2	PMOD	I-cell_type
O	O	O	446	448	by	by	B-PP	IN	O	1	NMOD	O
O	O	O	449	450	a	a	B-NP	DT	O	8	NMOD	O
O	O	O	451	462	combination	combination	I-NP	NN	O	6	PMOD	O
O	O	O	463	465	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	466	476	monoclonal	monoclonal	B-NP	JJ	B-protein	11	NMOD	B-protein
O	O	O	477	487	antibodies	antibody	I-NP	NNS	I-protein	9	PMOD	I-protein
O	O	O	488	496	directed	direct	B-VP	VBN	O	11	NMOD	O
O	O	O	497	499	at	at	B-PP	IN	O	12	VMOD	O
T6	B-Protein	B-Protein	500	503	CD2	CD2	B-NP	NN	B-protein	16	NMOD	B-protein
O	O	O	504	507	and	and	I-NP	CC	O	16	NMOD	O
T7	B-Protein	B-Protein	508	512	CD28	CD28	I-NP	NN	B-protein	18	NMOD	B-protein
O	O	O	513	521	adhesion	adhesion	I-NP	NN	B-protein	18	NMOD	B-protein
O	O	O	522	531	molecules	molecule	I-NP	NNS	I-protein	13	PMOD	I-protein
O	O	O	532	537	gives	give	B-VP	VBZ	O	0	ROOT	O
O	O	O	538	542	rise	rise	B-NP	NN	O	19	OBJ	O
O	O	O	543	545	to	to	B-PP	TO	O	19	VMOD	O
O	O	O	546	547	a	a	B-NP	DT	O	25	NMOD	O
O	O	O	548	552	long	long	I-NP	JJ	O	24	AMOD	O
O	O	O	553	560	lasting	lasting	I-NP	JJ	O	25	NMOD	O
O	O	O	561	574	proliferation	proliferation	I-NP	NN	O	21	PMOD	O
O	O	O	575	577	in	in	B-PP	IN	O	25	NMOD	O
O	O	O	578	581	the	the	B-NP	DT	O	28	NMOD	O
O	O	O	582	589	absence	absence	I-NP	NN	O	26	PMOD	O
O	O	O	590	592	of	of	B-PP	IN	O	28	NMOD	O
O	O	O	593	602	accessory	accessory	B-NP	NN	B-cell_type	31	NMOD	B-cell_type
O	O	O	603	608	cells	cell	I-NP	NNS	I-cell_type	29	PMOD	I-cell_type
O	O	O	608	609	.	.	O	.	O	19	P	O

T8	B-Protein	B-Protein	610	616	Cyclin	Cyclin	B-NP	NN	B-protein	2	NMOD	B-protein
T8	I-Protein	I-Protein	617	618	A	A	I-NP	NN	I-protein	3	SUB	I-protein
O	O	O	619	622	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	623	631	observed	observe	I-VP	VBN	O	3	VC	O
O	O	O	632	637	after	after	B-PP	IN	O	4	VMOD	O
O	O	O	638	639	4	4	B-NP	CD	O	7	NMOD	O
O	O	O	640	644	days	day	I-NP	NNS	O	5	PMOD	O
O	O	O	645	647	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	648	661	costimulation	costimulation	B-NP	NN	O	8	PMOD	O
O	O	O	662	666	with	with	B-PP	IN	O	9	NMOD	O
O	O	O	667	671	anti	anti	B-NP	JJ	B-protein	12	NMOD	B-protein
T9	B-Protein	B-Protein	672	675	CD2	CD2	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	O	676	677	+	+	I-NP	CC	O	14	NMOD	O
T10	B-Protein	B-Protein	678	682	CD28	CD28	I-NP	NN	B-protein	10	PMOD	B-protein
O	O	O	683	690	whereas	whereas	B-PP	IN	O	3	VMOD	O
O	O	O	691	702	stimulation	stimulation	B-NP	NN	O	24	SUB	O
O	O	O	703	705	by	by	B-PP	IN	O	16	NMOD	O
O	O	O	706	710	anti	anti	B-NP	JJ	B-protein	19	NMOD	B-protein
T11	B-Protein	B-Protein	711	714	CD2	CD2	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	O	715	717	or	or	O	CC	O	22	NMOD	O
O	O	O	718	722	anti	anti	B-NP	JJ	B-protein	22	NMOD	B-protein
T12	B-Protein	B-Protein	723	727	CD28	CD28	I-NP	NN	I-protein	17	PMOD	I-protein
O	O	O	728	733	alone	alone	B-ADVP	RB	O	22	NMOD	O
O	O	O	734	737	was	be	B-VP	VBD	O	15	SBAR	O
O	O	O	738	741	not	not	O	RB	O	24	VMOD	O
O	O	O	742	751	effective	effective	B-ADJP	JJ	O	24	PRD	O
O	O	O	751	752	.	.	O	.	O	3	P	O

O	O	O	753	755	In	In	B-NP	FW	O	2	AMOD	O
O	O	O	756	760	vivo	vivo	I-NP	FW	O	3	AMOD	O
O	O	O	761	768	genomic	genomic	I-NP	JJ	O	5	NMOD	O
O	O	O	769	772	DMS	DMS	I-NP	NN	O	5	NMOD	O
O	O	O	773	785	footprinting	footprinting	I-NP	NN	O	6	SUB	O
O	O	O	786	794	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	O	795	803	upstream	upstream	B-ADVP	RB	O	6	VMOD	O
O	O	O	804	806	of	of	B-PP	IN	O	7	AMOD	O
O	O	O	807	810	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	811	816	major	major	I-NP	JJ	B-DNA	13	NMOD	B-DNA
T21	B-Entity	B-Entity	817	830	transcription	transcription	I-NP	NN	I-DNA	13	NMOD	I-DNA
T21	I-Entity	I-Entity	831	841	initiation	initiation	I-NP	NN	I-DNA	13	NMOD	I-DNA
T21	I-Entity	I-Entity	842	847	sites	site	I-NP	NNS	I-DNA	8	PMOD	I-DNA
O	O	O	847	848	,	,	O	,	O	6	P	O
O	O	O	849	852	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	853	861	presence	presence	I-NP	NN	O	6	OBJ	O
O	O	O	862	864	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	865	867	at	at	B-NP	IN	O	17	PMOD	O
O	O	O	868	873	least	least	I-NP	JJS	O	18	AMOD	O
O	O	O	874	879	three	three	I-NP	CD	O	18	AMOD	O
T22	B-Entity	B-Entity	880	887	protein	protein	I-NP	NN	B-DNA	23	NMOD	B-DNA
T22	I-Entity	I-Entity	888	895	binding	binding	I-NP	NN	I-DNA	23	NMOD	I-DNA
T22	I-Entity	I-Entity	896	901	sites	site	I-NP	NNS	I-DNA	18	NMOD	I-DNA
O	O	O	901	902	,	,	O	,	O	18	P	O
O	O	O	903	906	two	two	B-NP	CD	O	26	NMOD	O
O	O	O	907	909	of	of	B-PP	IN	O	18	NMOD	O
O	O	O	910	915	which	which	B-NP	WDT	O	26	PMOD	O
O	O	O	916	920	were	be	B-VP	VBD	O	26	SBAR	O
O	O	O	921	935	constitutively	constitutively	I-VP	RB	O	28	VMOD	O
O	O	O	936	944	occupied	occupy	I-VP	VBN	O	28	VC	O
O	O	O	944	945	.	.	O	.	O	6	P	O

O	O	O	946	950	They	They	B-NP	PRP	O	2	SUB	O
O	O	O	951	955	bind	bind	B-VP	VBP	O	0	ROOT	O
O	O	O	956	958	in	in	B-ADVP	FW	O	2	VMOD	O
O	O	O	959	964	vitro	vitro	I-ADVP	FW	O	3	AMOD	O
O	O	O	965	977	respectively	respectively	B-NP	RB	O	2	VMOD	O
T13	B-Protein	B-Protein	978	981	ATF	ATF	I-NP	NN	B-protein	13	NMOD	B-protein
T13	I-Protein	I-Protein	981	982	-	-	B-NP	HYPH	O	13	P	O
T13	I-Protein	I-Protein	982	983	1	1	I-NP	CD	O	13	NMOD	O
O	O	O	984	987	and	and	I-NP	CC	O	13	NMOD	O
O	O	O	988	990	NF	NF	I-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	990	991	-	-	B-NP	HYPH	I-protein	13	NMOD	I-protein
O	O	O	991	992	Y	Y	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	O	993	1001	proteins	protein	I-NP	NNS	I-protein	2	OBJ	I-protein
O	O	O	1001	1002	.	.	O	.	O	2	P	O

O	O	O	1003	1006	The	The	B-NP	DT	O	3	NMOD	O
T23	B-Entity	B-Entity	1007	1012	third	third	I-NP	JJ	O	3	NMOD	O
T23	I-Entity	I-Entity	1013	1017	site	site	I-NP	NN	O	4	SUB	O
O	O	O	1018	1021	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1022	1030	occupied	occupy	I-VP	VBN	O	4	VC	O
O	O	O	1031	1033	in	in	B-PP	IN	O	5	VMOD	O
O	O	O	1034	1043	quiescent	quiescent	B-NP	JJ	B-cell_type	8	NMOD	B-cell_type
O	O	O	1044	1049	cells	cell	I-NP	NNS	I-cell_type	6	PMOD	I-cell_type
O	O	O	1050	1052	or	or	B-PP	CC	O	6	PMOD	O
O	O	O	1053	1055	in	in	B-PP	IN	O	6	PMOD	O
O	O	O	1056	1061	cells	cell	B-NP	NNS	O	10	PMOD	O
O	O	O	1062	1072	stimulated	stimulate	B-VP	VBN	O	11	NMOD	O
O	O	O	1073	1075	by	by	B-PP	IN	O	12	VMOD	O
O	O	O	1076	1080	anti	anti	B-NP	JJ	B-protein	15	NMOD	B-protein
T14	B-Protein	B-Protein	1081	1084	CD2	CD2	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	O	1085	1087	or	or	O	CC	O	18	NMOD	O
O	O	O	1088	1092	anti	anti	B-NP	JJ	B-protein	18	NMOD	B-protein
T15	B-Protein	B-Protein	1093	1097	CD28	CD28	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	O	1098	1103	alone	alone	B-ADVP	RB	O	18	NMOD	O
O	O	O	1103	1104	.	.	O	.	O	4	P	O

O	O	O	1105	1108	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	1109	1118	mitogenic	mitogenic	I-NP	JJ	O	3	NMOD	O
O	O	O	1119	1130	combination	combination	I-NP	NN	O	10	SUB	O
O	O	O	1131	1133	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	1134	1138	anti	anti	B-NP	JJ	B-protein	6	NMOD	B-protein
T16	B-Protein	B-Protein	1139	1142	CD2	CD2	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	O	1143	1144	+	+	O	CC	O	9	NMOD	O
O	O	O	1145	1149	anti	anti	B-NP	JJ	B-protein	9	NMOD	B-protein
T17	B-Protein	B-Protein	1150	1154	CD28	CD28	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	O	1155	1163	released	release	B-VP	VBD	O	0	ROOT	O
O	O	O	1164	1167	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	1168	1177	footprint	footprint	I-NP	NN	O	10	OBJ	O
O	O	O	1178	1180	as	as	B-SBAR	IN	O	10	VMOD	O
O	O	O	1181	1186	cells	cell	B-NP	NNS	O	15	SUB	O
O	O	O	1187	1191	were	be	B-VP	VBD	O	13	SBAR	O
O	O	O	1192	1201	committed	commit	I-VP	VBN	O	15	VC	O
O	O	O	1202	1204	to	to	B-PP	TO	O	16	VMOD	O
O	O	O	1205	1218	proliferation	proliferation	B-NP	NN	O	17	PMOD	O
O	O	O	1218	1219	.	.	O	.	O	10	P	O

O	O	O	1220	1230	Consistent	Consistent	B-ADJP	JJ	O	12	VMOD	O
O	O	O	1231	1235	with	with	B-PP	IN	O	1	AMOD	O
O	O	O	1236	1242	theses	theses	B-NP	DT	O	4	NMOD	O
O	O	O	1243	1250	results	result	I-NP	NNS	O	2	PMOD	O
O	O	O	1250	1251	,	,	O	,	O	12	P	O
O	O	O	1252	1259	nuclear	nuclear	B-NP	JJ	O	7	NMOD	O
O	O	O	1260	1268	extracts	extract	I-NP	NNS	O	12	SUB	O
O	O	O	1269	1277	prepared	prepare	B-VP	VBN	O	7	NMOD	O
O	O	O	1278	1282	from	from	B-PP	IN	O	8	VMOD	O
O	O	O	1283	1292	quiescent	quiescent	B-NP	JJ	B-cell_type	11	NMOD	B-cell_type
O	O	O	1293	1298	cells	cell	I-NP	NNS	I-cell_type	9	PMOD	I-cell_type
O	O	O	1299	1305	formed	form	B-VP	VBD	O	0	ROOT	O
O	O	O	1306	1307	a	a	B-NP	DT	O	15	NMOD	O
O	O	O	1308	1316	specific	specific	I-NP	JJ	O	15	NMOD	O
O	O	O	1317	1324	complex	complex	I-NP	NN	O	12	OBJ	O
O	O	O	1325	1329	with	with	B-PP	IN	O	15	NMOD	O
O	O	O	1330	1334	this	this	B-NP	DT	O	18	NMOD	O
O	O	O	1335	1342	element	element	I-NP	NN	O	16	PMOD	O
O	O	O	1342	1343	,	,	O	,	O	12	P	O
O	O	O	1344	1351	whereas	whereas	O	IN	O	12	VMOD	O
O	O	O	1352	1360	extracts	extract	B-NP	NNS	O	32	SUB	O
O	O	O	1361	1369	prepared	prepare	B-VP	VBN	O	21	NMOD	O
O	O	O	1370	1374	from	from	B-PP	IN	O	22	VMOD	O
O	O	O	1375	1380	cells	cell	B-NP	NNS	O	23	PMOD	O
O	O	O	1381	1388	treated	treat	B-VP	VBN	O	24	NMOD	O
O	O	O	1389	1393	with	with	B-PP	IN	O	25	VMOD	O
O	O	O	1394	1398	anti	anti	B-NP	JJ	B-protein	28	NMOD	B-protein
T18	B-Protein	B-Protein	1399	1402	CD2	CD2	I-NP	NN	I-protein	31	NMOD	I-protein
O	O	O	1403	1404	+	+	O	CC	O	31	NMOD	O
O	O	O	1405	1409	anti	anti	B-NP	JJ	B-protein	31	NMOD	B-protein
T19	B-Protein	B-Protein	1410	1414	CD28	CD28	I-NP	NN	I-protein	26	PMOD	I-protein
O	O	O	1415	1421	failed	fail	B-VP	VBD	O	20	SBAR	O
O	O	O	1422	1424	to	to	I-VP	TO	O	34	VMOD	O
O	O	O	1425	1427	do	do	I-VP	VB	O	32	VMOD	O
O	O	O	1428	1430	so	so	B-ADVP	RB	O	34	VMOD	O
O	O	O	1431	1436	after	after	B-SBAR	IN	O	32	VMOD	O
O	O	O	1437	1442	cells	cell	B-NP	NNS	O	38	SUB	O
O	O	O	1443	1450	entered	enter	B-VP	VBD	O	36	SBAR	O
O	O	O	1451	1452	a	a	B-NP	DT	O	41	NMOD	O
O	O	O	1453	1466	proliferative	proliferative	I-NP	JJ	O	41	NMOD	O
O	O	O	1467	1472	state	state	I-NP	NN	O	38	OBJ	O
O	O	O	1472	1473	.	.	O	.	O	12	P	O
